These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 715539)

  • 21. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.
    Sakakibara K; Nagase M; Takada Y; Takada A
    Thromb Res; 1987 Feb; 45(4):403-11. PubMed ID: 3576523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus nephritis: long-term follow-up.
    Cameron JS; Jones MB
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1187-91. PubMed ID: 4215066
    [No Abstract]   [Full Text] [Related]  

  • 23. Lupus Nephritis.
    Adu D; Cameron JS
    Clin Rheum Dis; 1982 Apr; 8(1):153-82. PubMed ID: 6214362
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fibrinogen-fibrin degradation products in glomerular diseases].
    Sasdelli M; Fabbri L; Cagnoli L; Zuccalà A
    Minerva Nefrol; 1973; 20(3):170-6. PubMed ID: 4761428
    [No Abstract]   [Full Text] [Related]  

  • 25. [Distribution of glomerular actin in renal diseases].
    Ebihara I
    Nihon Jinzo Gakkai Shi; 1983 Oct; 25(10):1243-54. PubMed ID: 6371335
    [No Abstract]   [Full Text] [Related]  

  • 26. Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy.
    Colasanti G; Morel Maroger L; D'Amico G
    Clin Nephrol; 1987 Jul; 28(1):28-34. PubMed ID: 3113791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lupus nephritis: clinico-immunological correlations based on studies of the complement system, fibrinogen (fibrin) degradation products and PHA-induced lymphocyte transformation].
    Szewczyk Z; Klinger M; Górecka Z; Ratajczak T; Melcer H
    Pol Arch Med Wewn; 1976 Nov; 56(5):419-31. PubMed ID: 1005168
    [No Abstract]   [Full Text] [Related]  

  • 28. Radiofibrinogen catabolism in nephritis.
    Wardle EN; Kerr DN
    Br Med J; 1975 Mar; 1(5956):489-91. PubMed ID: 123807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fibrinogen and fibrin degradation products in serum and their prognostic significance in acute myocardial infarct].
    Krug H; Gryglik J; Jasiński K; Gluszek J
    Kardiol Pol; 1977; 20(1):9-14. PubMed ID: 846061
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies of the metabolism of fibrinogen-I 125 in cases of chronic glomerulonephritis and pyelonephritis and in uremic patients treated by periodical hemodialysis].
    Huber W; Previato G; Bertoli M; Cancarini GC; Toigo G; Gasparotto ML; Romagnoli GF
    G Clin Med; 1975; 56(11-12):431-44. PubMed ID: 1233337
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nephrology in 1975].
    Lagrue G
    Rev Prat; 1975 Nov; 25(53):4137-42, 4145-6, 4151-4 passim. PubMed ID: 1209150
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of fibrin-degradation products in the diagnosis of glomerulonephritis in children].
    Sasinka M; Plenta I; Páleníková O; Pavlovic M; Getlík A; Kaiserová E
    Cesk Pediatr; 1979 Apr; 34(4):202-4. PubMed ID: 445644
    [No Abstract]   [Full Text] [Related]  

  • 33. [ Products of fibrin degradation in the urine during experimental and human glomerulonephritis].
    Lagrue G; Hirbec G; Gouault-Heilmann M; Levent M; Branellec A; Moisy M
    Pathol Biol (Paris); 1975 Jun; 23(6):486-91. PubMed ID: 1105353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of blood and urinary FDP fragments in patients with renal disease].
    Taura K
    Nihon Jinzo Gakkai Shi; 1983 Mar; 25(3):245-56. PubMed ID: 6887631
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies of blood sugar equilibrium in chronic nephropathies].
    Sdrobici D; Mătrescu F; Scridon G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(5):467-72. PubMed ID: 32601
    [No Abstract]   [Full Text] [Related]  

  • 36. [Albumin metabolism in chronic renal insufficiency].
    Kozlov VV; Rjabov SI
    Z Gesamte Inn Med; 1981 Nov; 36(22):889-91. PubMed ID: 7342514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of the determination of beta 2 microglobulin in kidney diseases].
    Potsybina VV; Baran EIa
    Urol Nefrol (Mosk); 1984; (3):53-6. PubMed ID: 6377647
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacokinetics of indomethacin in patients with kidney lesions].
    Traeger A; Stein G; Kunze M; Zaumseil J
    Int J Clin Pharmacol; 1972 Aug; 6(3):237-42. PubMed ID: 4648467
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the significance of serum soluble fibrin in nephritis, with special reference to the technique of staphylococcal clumping.
    Hayashi S
    Nihon Ketsueki Gakkai Zasshi; 1979 Feb; 42(1):53-64. PubMed ID: 371323
    [No Abstract]   [Full Text] [Related]  

  • 40. [Correlation between products of fibrin degradation and platelet dysfunction in chronic renal failure. Effects of aspirin].
    Lazzari MA; Pavlovsky M; Martínez Canaveri A
    Medicina (B Aires); 1977; 37(2):97-105. PubMed ID: 895494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.